These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29610253)

  • 21. Role of adherence of Streptococcus pneumoniae in acute otitis media.
    Andersson B; Gray BM; Dillon HC; Bahrmand A; Edén CS
    Pediatr Infect Dis J; 1988 Jul; 7(7):476-80. PubMed ID: 3405650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The central role of pneumococcal colonization in the pathogenesis and control of pneumococcal diseases.
    Howard LM; Grijalva CG
    Future Microbiol; 2018 Oct; 13():1453-1456. PubMed ID: 30311793
    [No Abstract]   [Full Text] [Related]  

  • 23. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
    van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
    Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do antibodies to pneumococcal surface adhesin a prevent pneumococcal involvement in acute otitis media?
    Rapola S; Kilpi T; Lahdenkari M; Takala AK; Mäkelä PH; Käyhty H
    J Infect Dis; 2001 Sep; 184(5):577-81. PubMed ID: 11494164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children: implications for the use of heptavalent pneumococcal conjugate vaccine.
    Marchisio P; Esposito S; Schito GC; Marchese A; Cavagna R; Principi N;
    Emerg Infect Dis; 2002 May; 8(5):479-84. PubMed ID: 11996682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
    Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of Streptococcus pneumoniae in upper respiratory tract cultures and a decreased incidence of related acute otitis media following introduction of childhood pneumococcal conjugate vaccines in a Swedish county.
    Littorin N; Ahl J; Uddén F; Resman F; Riesbeck K
    BMC Infect Dis; 2016 Aug; 16(1):407. PubMed ID: 27514843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
    Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
    Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France.
    Cohen R; Levy C; Bonnet E; Grondin S; Desvignes V; Lecuyer A; Fritzell B; Varon E
    Vaccine; 2010 Aug; 28(37):6114-21. PubMed ID: 19490958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers.
    Dagan R; Givon-Lavi N; Zamir O; Sikuler-Cohen M; Guy L; Janco J; Yagupsky P; Fraser D
    J Infect Dis; 2002 Apr; 185(7):927-36. PubMed ID: 11920317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution.
    Dagan R; Leibovitz E; Greenberg D; Bakaletz L; Givon-Lavi N
    J Infect Dis; 2013 Oct; 208(7):1152-60. PubMed ID: 23842949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 10-valent pneumococcal conjugate vaccine (PCV10) decreases metabolic activity but not nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae.
    Andrade DC; Borges IC; Bouzas ML; Oliveira JR; Fukutani KF; Queiroz AT; de Oliveira CI; Barral A; Van Weyenbergh J; Nascimento-Carvalho C
    Vaccine; 2017 Jul; 35(33):4105-4111. PubMed ID: 28668567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media.
    Cohen R; Levy C; de La Rocque F; Gelbert N; Wollner A; Fritzell B; Bonnet E; Tetelboum R; Varon E
    Pediatr Infect Dis J; 2006 Nov; 25(11):1001-7. PubMed ID: 17072121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in children with acute respiratory infection with or without nasopharyngeal bacterial carriage.
    Andrade DC; Borges IC; Bouzas ML; Oliveira JR; Käyhty H; Ruuskanen O; Nascimento-Carvalho C
    Infect Dis (Lond); 2018 Sep; 50(9):705-713. PubMed ID: 29688138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic immunization with rPotD reduces Streptococcus pneumoniae nasopharyngeal colonization in mice.
    Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LC
    Vaccine; 2017 Jan; 35(1):149-155. PubMed ID: 27884476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Streptococcus pneumoniae and Haemophilus influenzae isolated from middle ear fluid before and after the introduction of government subsidies for pneumococcal and H. influenzae type b vaccines in Japan.
    Hoshino T; Takeuchi N; Fukasawa C; Hirose S; Okui H; Sato H; Sato M; Arimoto Y; Nakano A; Ishiwada N
    J Infect Chemother; 2017 Feb; 23(2):85-89. PubMed ID: 27889249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.
    Millar EV; Watt JP; Bronsdon MA; Dallas J; Reid R; Santosham M; O'Brien KL
    Clin Infect Dis; 2008 Oct; 47(8):989-96. PubMed ID: 18781875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic resistance and the potential impact of pneumococcal conjugate vaccines.
    Dagan R
    Commun Dis Intell Q Rep; 2003; 27 Suppl():S134-42. PubMed ID: 12807290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.
    Prymula R; Peeters P; Chrobok V; Kriz P; Novakova E; Kaliskova E; Kohl I; Lommel P; Poolman J; Prieels JP; Schuerman L
    Lancet; 2006 Mar; 367(9512):740-8. PubMed ID: 16517274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.